← Back to all trials
Recruiting
NCT07816692
iDose TR Administration in an Office-Based Surgery Setting
Conditions: Open Angle Glaucoma (OAG), Ocular Hypertension (OHT)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 30
Sponsor: Glaukos Corporation
Location: Glaukos Investigative Site Austin Texas
Summary
Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of Open angle glaucoma (OAG) or ocular hypertension (OHT)
Exclusion Criteria:
* Prior administration of iDose TR or administration of an investigational intracameral implant in the study eye Active ocular infection or inflammation History of hypersensitivity to travoprost or implant components Recent ocular surgery Uncontrolled systemic disease Any condition preventing safe implantation
Source: ClinicalTrials.gov (NCT07816692). StuddyBuddy aggregates publicly available trial information.
